Published in Br J Cancer on November 01, 1994
Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst (1997) 2.83
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68
Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut (2000) 1.50
Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am J Pathol (1999) 1.41
Cause and consequences of genetic and epigenetic alterations in human cancer. Curr Genomics (2008) 1.31
Different molecular patterns in glioblastoma multiforme subtypes upon recurrence. J Neurooncol (2009) 1.17
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A. Neoplasia (2008) 1.17
Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting. Proc Natl Acad Sci U S A (1998) 0.96
Evaluation of the clonal origin of multiple primary melanomas using molecular profiling. J Invest Dermatol (2009) 0.96
Neoplasms associated with germline and somatic NF1 gene mutations. Oncologist (2012) 0.95
Loss of heterozygosity: an independent prognostic factor of colorectal cancer. World J Gastroenterol (2005) 0.94
The NF1 gene revisited - from bench to bedside. Oncotarget (2014) 0.91
Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability. Int J Colorectal Dis (2012) 0.91
Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients. Br J Cancer (2000) 0.90
Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme. J Cancer Res Clin Oncol (2004) 0.89
Allelic imbalance in oral lichen planus and assessment of its classification as a premalignant condition. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2011) 0.88
What we could do now: molecular pathology of colorectal cancer. Mol Pathol (2001) 0.88
nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J Clin Pathol (2004) 0.87
NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. Br J Cancer (1996) 0.87
Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequence. Br J Cancer (2000) 0.86
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation. Cancer Res (2007) 0.86
NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas. Br J Cancer (1998) 0.84
Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients. Br J Cancer (1999) 0.82
The scope of quantitative polymerase chain reaction assays in clinical molecular pathology. Clin Mol Pathol (1995) 0.82
Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells. PLoS One (2011) 0.81
Significance of genetic abnormalities of p53 protein in Slovenian patients with gastric carcinoma. Croat Med J (2007) 0.81
Genetic prognostic markers in colorectal cancer. Mol Pathol (1997) 0.79
[Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias]. Mund Kiefer Gesichtschir (2007) 0.77
Dysregulated methylation at imprinted genes in prostate tumor tissue detected by methylation microarray. BMC Urol (2013) 0.76
Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors. PLoS One (2012) 0.75
Allelic imbalance and microsatellite instability of the DCC gene in colorectal cancer in patients under the age of 35 using fluorescent DNA technology. Mol Pathol (1998) 0.75
Fluorescent polymerase chain reaction of a panel of CA repeats on chromosome 6 in the indolent phase of follicular centre cell lymphoma. Br J Cancer (1996) 0.75
The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics (2017) 0.75
Impact of chromosome 17q deletion in the primary lesion of colorectal cancer on liver metastasis. Oncol Lett (2016) 0.75
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet (1989) 62.23
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Microsatellite instability in cancer of the proximal colon. Science (1993) 14.51
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (1993) 12.74
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet (1992) 3.89
Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell (1992) 3.20
An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell (1990) 3.02
Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet (1989) 2.68
A study of the origin of 'shadow bands' seen when typing dinucleotide repeat polymorphisms by the PCR. Hum Mol Genet (1993) 2.22
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer (1992) 1.77
Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet (1991) 1.74
A CA repeat 30-70 KB downstream from the adenomatous polyposis coli (APC) gene. Nucleic Acids Res (1991) 1.69
Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res (1992) 1.65
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene (1989) 1.52
Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst (1991) 1.40
CA repeat polymorphism at the D5S82 locus, proximal to adenomatous polyposis coli (APC). Nucleic Acids Res (1991) 1.29
Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst (1993) 1.22
Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer (1993) 1.21
A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1 (NF1) gene. Hum Genet (1993) 1.21
CA repeat polymorphism at the D5S299 locus linked to adenomatous polyposis coli (APC). Nucleic Acids Res (1991) 1.18
Dinucleotide repeat polymorphism in the human DCC gene at chromosome 18q21. Hum Mol Genet (1992) 1.18
An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res (1991) 1.15
Loss of heterozygosity detected in formalin-fixed, paraffin-embedded tissue of colorectal carcinoma using a microsatellite located within the deleted in colorectal carcinoma gene. Diagn Mol Pathol (1993) 1.13
Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. Br J Cancer (1991) 1.12
Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res (1993) 1.08
PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue. Br J Cancer (1993) 1.06
Follow-up of retinoblastoma patients having prenatal and perinatal predictions for mutant gene carrier status using intragenic polymorphic probes from the RB1 gene. Br J Cancer (1992) 0.94
Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors. J Natl Cancer Inst (1992) 0.90
The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17. Br J Cancer (1993) 0.85
Genetic alteration in gastrointestinal cancer. A molecular and cytogenetic study. Anticancer Res (1994) 0.83
The Nm23 gene and colorectal cancer. Gut (1994) 0.82
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut (2008) 5.86
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med (1991) 5.04
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73
Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg (2010) 3.63
Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol (1993) 3.34
Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J Clin Pathol (1990) 3.30
Cost effectiveness of antenatal screening for cystic fibrosis. BMJ (1995) 3.05
Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg (2010) 3.03
Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg (2012) 2.93
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Unlocking the archive--gene expression in paraffin-embedded tissue. J Pathol (2001) 2.76
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature (1995) 2.52
Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg (2010) 2.23
The broad reach of helminthology. Science (2001) 2.18
Enterovirus type 71 infection in Melbourne. Bull World Health Organ (1974) 2.16
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology (2007) 2.01
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70
Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69
DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet (2002) 1.68
Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum (1998) 1.66
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
Methylation and colorectal cancer. J Pathol (2001) 1.61
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut (1995) 1.58
Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma. J Pathol (1989) 1.57
An epidemic associated with echovirus type 18. J Hyg (Lond) (1972) 1.57
Sensitive in situ hybridisation technique using biotin-streptavidin-polyalkaline phosphatase complex. J Clin Pathol (1987) 1.56
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut (1990) 1.56
CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med (1998) 1.56
Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg (1995) 1.54
Familial transmission of the FMR1 CGG repeat. Am J Hum Genet (1996) 1.53
Allelic drop-out and preferential amplification in single cells and human blastomeres: implications for preimplantation diagnosis of sex and cystic fibrosis. Hum Reprod (1995) 1.52
Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut (2000) 1.50
Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut (2001) 1.49
Frequency of replication errors in colorectal cancer and their association with family history. Gut (1998) 1.46
Abnormal intestinal permeability. An aetiological factor in chronic psychiatric disorders? Br J Psychiatry (1987) 1.45
Assessment of microsatellite alterations in young patients with gastric adenocarcinoma. Cancer (1997) 1.45
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology (1993) 1.45
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
MRI assessment of the bony pelvis may help predict resectability of rectal cancer. Colorectal Dis (2005) 1.43
Colorectal cancer reporting: are we failing the patient? J Clin Pathol (1997) 1.42
Prognostic indicators in centroblastic-centrocytic lymphoma. J Clin Pathol (1988) 1.41
DNA aneuploidy in ulcerative colitis. Gut (1986) 1.38
ACP Broadsheet 133: November 1992. Gross examination of the stomach. J Clin Pathol (1992) 1.38
Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg (1993) 1.38
Adenovirus type 4 in Melbourne, 1969-1971. Med J Aust (1974) 1.38
The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer (2010) 1.37
Patient factors influencing conversion from laparoscopically assisted to open surgery for colorectal cancer. Br J Surg (2008) 1.37
Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. Br J Cancer (1985) 1.34
Large-scale laboratory maintenance of Schistosoma mansoni, with observations on three schistosome/snail host combinations. J Parasitol (1986) 1.33
Detection of measles virus RNA in paraffin-embedded tissue. Lancet (1989) 1.32
DNA aneuploidy in colorectal adenomas. Br J Cancer (1986) 1.32
Molecular biology of colorectal neoplasia. Gut (1993) 1.31
Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol (1994) 1.30
Adenoma screening and colorectal cancer. BMJ (1991) 1.26
Adoptive suppression of granuloma formation by T lymphocytes and by lymphoid cells sensitive to cyclophosphamide. Cell Immunol (1979) 1.23
A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer (2012) 1.21
Evaluation of the role of pre-operative magnetic resonance imaging in the management of rectal cancer. Colorectal Dis (2001) 1.21
Fluorescent polymerase chain reaction: Part I. A new method allowing genetic diagnosis and DNA fingerprinting of single cells. Hum Reprod Update (1997) 1.17
Flow cytometry: methodology and applications in pathology. J Pathol (1986) 1.17
Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia. Oncogene (2006) 1.17
Demonstration of multiple HPV types in normal cervix and in cervical squamous cell carcinoma using the polymerase chain reaction on paraffin wax embedded material. J Clin Pathol (1990) 1.16
Immune responses during human schistosomiasis mansoni. IV. Induction of suppressor cell activity by schistosome antigen preparations and concanavalin A. J Immunol (1978) 1.15
Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors. Oncogene (2006) 1.15
Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep (2005) 1.15
Overexpression of HER2/neu in solid tumours: an immunohistochemical survey. Histopathology (2001) 1.13
A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol (2011) 1.10
A study of the prevalence of rotavirus infection in children with gastroenteritis admitted to an infectious diseases hospital. J Med Virol (1977) 1.10
Comparison of rhinovirus-sensitive HeLa cells and human embryo fibroblasts for isolation of rhinoviruses from patients with respiratory disease. J Clin Microbiol (1976) 1.10
Short-term costs of conventional vs laparoscopic assisted surgery in patients with colorectal cancer (MRC CLASICC trial). Br J Cancer (2006) 1.10
Helicobacter pylori infection and dental care. Gut (1995) 1.10
Comparison of treatment and outcome information between a clinical trial and the National Cancer Data Repository. Br J Surg (2011) 1.09
Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol (1994) 1.09
Cancer's craving for sugar: an opportunity for clinical exploitation. J Cancer Res Clin Oncol (2009) 1.09
Genetics of Biomphalaria glabrata and its effect on the outcome of Schistosoma mansoni infection. Parasitol Today (1992) 1.08
In situ hybridization technique using an immunogold silver staining system. Histochem J (1989) 1.08
DNA fingerprinting from single cells. Nature (1997) 1.07
The 1976 influenza epidemic in Melbourne. Med J Aust (1978) 1.07
Acute changes in nucleic acid synthesis induced by carcinogens in mouse bladder. Biochem J (1969) 1.07
Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut (1993) 1.07
Parathyroid hormone-related peptide in normal human fetal development. J Mol Endocrinol (1990) 1.06
Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer? Br J Cancer (1986) 1.06